. 2022 Jul 21;21:60. doi: 10.1186/s12944-022-01673-3

Table 2.

Partial correlation analyses for the associations between TMAO-related metabolites and lipids before rosuvastatin therapy (n = 112)

Variables	TMAO		Choline		Carnitine		Betaine		GBB
Variables	r	P	r	P	r	P	r	P	r	P
TG	0.294	0.002	−0.020	0.839	−0.046	0.632	−0.008	0.936	−0.135	0.161
TC	0.156	0.106	0.093	0.338	0.073	0.451	−0.093	0.334	0.075	0.439
HDL-c	−0.316	0.001	−0.098	0.313	−0.009	0.923	−0.105	0.275	0.003	0.977
LDL-c	0.040	0.680	−0.037	0.702	−0.090	0.351	−0.269	0.005	0.043	0.654
ApoA1	−0.081	0.404	−0.075	0.441	0.070	0.468	−0.086	0.373	−0.035	0.715
ApoB	0.021	0.828	0.096	0.320	0.042	0.668	−0.028	0.772	0.076	0.429

TMAO Trimethylamine N-oxide, TG Triglycerides, TC Total cholesterol, HDL-c High-density lipoprotein cholesterol, LDL-c Low-density lipoprotein cholesterol, ApoA1 Apolipoprotein A1, ApoB Apolipoprotein B, GBB γ-butyrobetaine. Partial correlation was performed by controlling for sex, age, body mass index and estimated glomerular filtration rate.